CDK 4/6 Inhibitors in HR+/HER2- Breast Cancer – Ayer, MA

Nashoba Valley Medical Center 200 Groton Rd., Ayer

This program will review the use of CDK 4/6 inhibitors in the treatment of HR+/HER2-negative breast cancer and the management of treatment-related adverse events.

HCC GR 45 – Hudson, NY

This live activity is focused on treatment strategies for patients with hepatocellular carcinoma (HCC).